Beta Drugs Price Change Analysis
Beta Drugs Key Statistics
-
P/E Ratio
58.6
-
PEG Ratio
-
Market Cap Cr
810.6
-
Price to Book Ratio
80.6
-
EPS
14.8
-
Dividend
0 ()
-
Relative Strength Index
62.33
-
Money Flow Index
70.56
-
MACD Signal
66.2
-
Average True Range
60.7
Investment Ratings
-
Master Rating:
-
EPS Strength
Price Strength
Buyer Demand
Group Rank
Result Highlights
Beta Drugs Synopsis
NSE-Medical-Diversified
Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 124.85 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2022. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.-
Market Cap
825.84
-
Sales
124.85
-
Shares in Float
-
No of Funds
1
-
Yield
-
Book Value
10.79
-
U/D Vol Ratio
1.5
-
LTDebt/Equity
7
-
Alpha
0.52
-
Beta
0.86
Beta Drugs Ownership
| Owner Name | Jun-21 |
|---|---|
| Promoters | 66.68% |
| Foreign Portfolio Investors | 0.27% |
| Others | 33.05% |
Beta Drugs Management
| Name | Designation |
|---|---|
| Mr. Rahul Batra | Chairman & Managing Director |
| Mr. Varun Batra | Joint Managing Director |
| Mr. Balwant Singh | Whole Time Director |
| Mrs. Seema Chopra | Whole Time Director |
| Mr. Manmohan Khanna | Independent Director |
| Mr. Rohit Parti | Independent Director |
Beta Drugs Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Eps And Sales Estimates
Beta Drugs Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
Beta Drugs Technicals
EMA & SMA
CURRENT PRICE
EMA
Beta Drugs Resistance and Support
Beta Drugs Delivery and Volume
Beta Drugs Price Change Analysis
Corporate Action
Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|
Videos
About Company
News
FAQs
Beta Drugs share price is